British drug major AstraZeneca, which had halted the trial of coronavirus vaccine AZD1222 last week, has resumed the trial in the U.K, while it is still not certain when the company will start its US trial again. The company said it will continue to work with other global health authorities and be guided as to when other clinical trials can resume.
from RTT - Biotech https://ift.tt/32rZIte
via IFTTT
No comments:
Post a Comment